Topic:

Chutes and Ladders

Latest Headlines

Latest Headlines

Novartis names two new leaders to growth drivers Alcon, Sandoz

Novartis, amid a company-wide strategic review, has said some of its underperforming units may be on the way out. But as it draws up its blueprints for the future, it's also working to bolster its star businesses, and Wednesday it announced some changes at the top of two of its key divisions.

Novartis gets new head of Japanese business amid misconduct investigations

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

GTx's CEO finds the door as the company moves on from a PhIII failure

After nearly 25 years at biotech GTx, CEO Mitchell Steiner has stepped down from the top spot, leaving behind a drug developer working to salvage its pipeline after a devastating late-stage setback.

Novartis ousts top Japanese execs amid fresh misconduct allegations

Novartis has cracked down on its Japanese management. The Swiss drugmaker pushed out its top three executives Thursday, after a scathing report from a panel investigating misconduct in a leukemia drug trial.

Sanofi taps outcomes exec for new C-level job as 'patient officer'

Last week, Johnson & Johnson chalked up a Big Pharma first by hiring a chief design officer. This week, the groundbreaker is Sanofi. The job? Chief Patient Officer.

Merck appoints Baxter exec to fill chief financial officer role

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Biogen's Scangos joins Agilent board

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Amgen names Piacquad senior VP of business development

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Roche's pRED taps Vanderbilt cancer director as new oncology chief

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Novartis' Reinhardt chairmanship officially begins, as Vasella's era fades

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...